FDA Approved: JANTOVEN — Supplemental Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for Jantoven (warfarin sodium) submitted by Upsher-Smith Laboratories.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Deep Vein Thrombosis
• Mechanical Heart Valve Thrombosis Prophylaxis
• Pulmonary Embolism
• Valvular Heart Disease
• Venous Thromboembolism

Drugs mentioned

• JANTOVEN (WARFARIN SODIUM)

Snippet

SUPPL AP for JANTOVEN (WARFARIN SODIUM)